GleamWall
中文EN

LNTH Lantheus Holdings, Inc.

In Vitro & In Vivo Diagnostic Substances · Nasdaq · SEC CIK 1521036 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.4%
TTM net income YoY61.0%
TTM EPS YoY66.8%
Revenue 3-yr CAGR9.0%
Net income 3-yr CAGR37.4%

Margins

Gross margin61.3%
Operating margin18.6%
Net margin17.3%
FCF margin25.2%
EBITDA margin24.4%

Returns

ROE21.8%
ROA11.4%
ROIC (approx.)18.0%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets44.8%
Debt / equity0.42x
Current ratio3.25x
Interest coverage14.70x

Cash quality & payout

Operating cash flow / net income1.52x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$389.91M$388.18M$377.33M$406.79M$384.01M$378.05M$372.76M$391.11M
Cost of revenue$146.50M$146.32M$146.41M$165.91M$161.65M$137.03M$135.06M$142.56M
Gross profit$243.41M$241.85M$230.92M$240.88M$222.37M$241.01M$237.70M$248.54M
R&D expense$92.76M$38.20M$39.38M$47.48M$48.02M$45.49M$36.31M$35.33M
SG&A expense$70.38M$20.63M$57.53M$69.89M$81.90M$66.52M$56.82M$57.87M
Operating income$32.21M$100.22M$81.33M$77.18M$43.62M$87.97M$102.07M$113.87M
Interest expense$4.94M$4.92M$4.86M$5.08M$4.95M$4.92M$4.80M$5.04M
Pretax income$21.78M$93.83M$156.41M$70.36M$42.38M$104.52M$96.53M-$783,000
Income tax-$594,000$18.80M$37.99M$16.28M$14.61M$25.76M$23.58M$11.01M
Net income$22.37M$75.03M$118.42M$54.09M$27.77M$78.75M$72.94M-$11.79M
EBITDA$55.10M$122.80M$104.01M$100.02M$64.02M$101.20M$115.69M$131.16M
EPS (basic)0.341.151.83—0.411.151.06—
EPS (diluted)0.331.111.80—0.411.121.02—
Weighted avg. shares (diluted)68.41M67.52M65.77M—67.66M70.31M71.46M—
Balance sheet
Cash & equivalents$683.61M$593.30M$595.01M$359.12M$382.01M$695.57M$697.26M$914.49M
Receivables$345.68M$352.89M$355.67M$358.64M$351.38M$336.58M$348.75M$321.26M
Inventory$64.21M$57.55M$61.34M$64.67M$62.04M$62.16M$69.13M$68.03M
Current assets$1.12B$1.03B$942.29M$899.96M$925.09M$1.20B$1.42B$1.33B
PP&E, net$149.63M$153.27M$157.56M$163.69M$164.07M$157.73M$180.78M$176.80M
Goodwill$238.63M$239.05M$239.40M$239.52M$240.33M$176.87M$61.19M$61.19M
Intangibles$641.61M$689.34M$706.06M$722.78M$739.26M$359.95M$153.75M$161.76M
Total assets$2.46B$2.41B$2.35B$2.23B$2.28B$2.12B$2.06B$1.98B
Current liabilities$345.97M$335.68M$333.17M$333.42M$346.84M$280.13M$248.00M$240.53M
Short-term debt$605,000$697,000$803,000$738,000$871,000$796,000$747,000$974,000
Long-term debt$571.14M$570.35M$569.60M$568.68M$567.94M$566.85M$566.10M$565.28M
Total debt$571.74M$571.05M$570.41M$569.42M$568.81M$567.64M$566.85M$566.25M
Total liabilities$1.10B$1.10B$1.13B$1.14B$1.16B$949.29M$891.03M$892.33M
Shareholders' equity$1.36B$1.31B$1.21B$1.09B$1.12B$1.17B$1.16B$1.09B
Net debt-$111.87M-$22.25M-$24.61M$210.29M$186.80M-$127.93M-$130.42M-$348.23M
Shares outstanding65.37M65.27M65.07M64.59M71.77M71.70M71.61M68.45M
Cash flow statement
Operating cash flow$101.97M$92.20M$125.13M$90.18M$105.29M$87.11M$107.56M$157.73M
Capital expenditure$2.05M$2.33M$3.23M$8.79M$10.62M$7.96M$8.72M$16.37M
Free cash flow$99.93M$89.87M$121.90M$81.39M$94.67M$79.14M$98.84M$141.36M
Investing cash flow-$11.13M-$2.02M$25.99M-$11.51M-$319.47M-$232.47M-$63.72M-$6.60M
Financing cash flow-$460,000$4.50M-$11.62M-$100.79M-$99.17M-$98.41M-$18.22M-$103.66M
Depreciation & amortization$22.90M$22.58M$22.68M$22.83M$20.41M$13.23M$13.63M$17.29M
Stock-based compensation$21.88M$20.01M$16.04M$17.54M$24.50M$22.32M$21.20M$22.16M
Share buybacks$0——$100.02M$100.00M——$100.00M

Free plan shows the latest 8 periods; Pro shows all 51 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.